Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Genzyme and Isis Pharmaceuticals: Phase 3 mipomersen study in heFH patients meets primary endpoint

Genzyme Corp. and Isis Pharmaceuticals Inc. today announced that the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) met its primary endpoint with a highly statistically significant 28 percent reduction in LDL-cholesterol after 26 weeks of treatment, compared with an increase of 5 percent for placebo.

10 Feb 2010

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

Commenting on the Group's 2009 performance, sanofi-aventis Chief Executive Officer Christopher A. Viehbacher said, "2009 was the first year of implementation of our new strategy. Major steps have already been achieved in strengthening our growth platforms and reinforcing our R&D pipeline while delivering a double-digit EPS(1) growth".

10 Feb 2010

DTM programs increase adherence to injectable medications and treatment persistence in MS patients

A new study reveals that multiple sclerosis (MS) patients enrolled in a seven-month disease therapy management (DTM) program show greater adherence to injectable MS medications and treatment persistence than patients who receive injectable MS medications through a community pharmacy.

10 Feb 2010

Patients treated with Biodesign Inguinal Hernia Graft experience less postoperative pain

Results from a clinical study led by Luca Ansaloni, M.D., showed that Cook Medical’s Biodesign Inguinal Hernia Graft causes less postoperative pain and discomfort while creating a repair as durable as synthetic mesh when used in Lichtenstein’s hernioplasty procedures.

10 Feb 2010

New method may help assess impact and cost-effectiveness of flu vaccination campaigns

A new study (doi:10.1016/j.vaccine.2010.01.002), published by Elsevier this month in Vaccine (http://www.elsevier.com/locate/vaccine) describes a new method that assesses the impact and cost-effectiveness of a range of vaccination options.

10 Feb 2010

Cerus enters into collaborative agreement with EFS for development of INTERCEPT Blood System

Cerus Corporation announced today that it has entered into a collaborative agreement with France's national transfusion service, the Etablissement Français du Sang (EFS), for the development of the company's INTERCEPT Blood System for red blood cells.

10 Feb 2010

Unassisted cessation proves to be most successful in quitting smoking

Health authorities should emphasize the positive message that the most successful method used by most ex-smokers is unassisted cessation, despite the promotion of cessation drugs by pharmaceutical companies and many tobacco control advocates.

10 Feb 2010

VSV has potential to be genetically modified to serve as anti-cancer agent

Vesicular stomatitis virus, or VSV, has long been a model system for studying and understanding the life cycle of negative-strand RNA viruses, which include viruses that cause influenza, measles and rabies.

10 Feb 2010

Children with depressive symptoms may have greater affinity for sweets, says study

New research from the Monell Center reports that children's response to intense sweet taste is related to both a family history of alcoholism and the child's own self-reports of depression.

10 Feb 2010

Dana-Farber Cancer Institute, Sanford-Burnham Medical Research Institute sign license agreement with Genentech, Roche

Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, a wholly owned member of the Roche group, and Roche, that grants the companies exclusive rights to manufacture, develop and market human monoclonal antibodies to treat and protect against group 1 influenza viruses.

10 Feb 2010

Loyola University Chicago offers new research-intensive program for healthcare industry

Registration is underway for Loyola University Chicago's new infectious disease & immunology master's degree program that will prepare graduates for challenging health-related positions in government, research and private industry.

10 Feb 2010

Health officials encourage caution, despite H1N1 case decline

As the number of new H1N1 (swine flu) infections worldwide drops, U.S. health officials on Friday cautioned the virus continues to circulate and can still be deadly, Reuters reports. According to the WHO, H1N1 remains the dominant strain worldwide, but there are reports of the recent emergence of the seasonal flu in Africa and China, according to the news agency.

10 Feb 2010

Whooping cough vaccine may be losing its punch: study

Vaccination programs against whooping cough may not be fully effective because the bacteria that cause the disease have evolved new strains, a new study has found.

9 Feb 2010

Triple-S Management reports consolidated revenues of $516.9 million for fourth-quarter 2009

Triple-S Management Corporation, the largest managed care company in Puerto Rico, today announced consolidated revenues of $516.9 million and operating income of $34.2 million for the three months ended December 31, 2009.

9 Feb 2010

First Edition: February 9, 2010

Today's headlines reveal more reactions to President Obama's bi-partisan health care summit. Chief among them are low expectations.

9 Feb 2010

Centene announces fourth quarter and full year 2009 financial results

Centene Corporation today announced its financial results for the quarter and year ended December 31, 2009. The results of operations for our New Jersey health plan, University Health Plans, are classified as discontinued operations.

9 Feb 2010

Study validates Transgenomic's COLD-PCR technology for colorectal tumor-associated KRAS mutation detection

Transgenomic, Inc. announced today that it has completed a preliminary study with a leading pharmaceutical company that validates the use of its licensed COLD-PCR technology to detect colorectal tumor-associated KRAS mutations that determine efficacy of recently developed therapies. These were detected in plasma samples in which the mutation levels were too low for detection by standard DNA analysis methodologies such as Sanger sequencing.

9 Feb 2010

Researchers explore cellular networks that regulate cell morphology

Cellular imaging offers a wealth of data about how cells respond to stimuli, but harnessing this technique to study biological systems is a daunting challenge.

9 Feb 2010

USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza

NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules". This patent covers NexBio's sialidase pharmaceutical compositions, including its lead compound DAS181 (Fludase®), and methods of treating or preventing viral infection by influenza and parainfluenza with such compositions.

9 Feb 2010

Novavax announces new data from trivalent seasonal influenza VLP vaccine study

Novavax, Inc. announced today new data from a clinical study that began in May of 2009 among healthy adults 18 to 49 years of age with Novavax's trivalent seasonal influenza Virus-like Particle (VLP) vaccine. The vaccine matched the influenza strains recommended for the 2008-2009 influenza season including H1N1 A/Brisbane/59/2007, H3N2 A/Brisbane/10/2007, and B/Florida/04/2006 strains.

9 Feb 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Genzyme and Isis Pharmaceuticals: Phase 3 mipomersen study in heFH patients meets primary endpoint

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

DTM programs increase adherence to injectable medications and treatment persistence in MS patients

Patients treated with Biodesign Inguinal Hernia Graft experience less postoperative pain

New method may help assess impact and cost-effectiveness of flu vaccination campaigns

Cerus enters into collaborative agreement with EFS for development of INTERCEPT Blood System

Unassisted cessation proves to be most successful in quitting smoking

VSV has potential to be genetically modified to serve as anti-cancer agent

Children with depressive symptoms may have greater affinity for sweets, says study

Dana-Farber Cancer Institute, Sanford-Burnham Medical Research Institute sign license agreement with Genentech, Roche

Loyola University Chicago offers new research-intensive program for healthcare industry

Health officials encourage caution, despite H1N1 case decline

Whooping cough vaccine may be losing its punch: study

Triple-S Management reports consolidated revenues of $516.9 million for fourth-quarter 2009

First Edition: February 9, 2010

Centene announces fourth quarter and full year 2009 financial results

Study validates Transgenomic's COLD-PCR technology for colorectal tumor-associated KRAS mutation detection

Researchers explore cellular networks that regulate cell morphology

USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza

Novavax announces new data from trivalent seasonal influenza VLP vaccine study

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in